Japan Alzheimer's Disease Market Forecast to 2032 Demonstrates Increasing Diagnosed Prevalence and Growth Following Novel Treatment Approaches
January 25, 2024 09:02 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Japan Alzheimer's Disease - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The...
Global Alzheimer's Disease Industry Forecast, 2032: Breakthrough Therapies and Market Trends
August 23, 2023 05:53 ET
|
Research and Markets
Dublin, Aug. 23, 2023 (GLOBE NEWSWIRE) -- The "Global Alzheimer's Disease Market 2023-2032" report has been added to ResearchAndMarkets.com's offering. Alzheimer's disease, a progressive...
Global Alzheimer's Disease Therapeutics Market Research Report 2023: Forecasts, Epidemiology & Pipeline Analysis 2022-2028
February 08, 2023 10:23 ET
|
Research and Markets
Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The "Alzheimer's Disease Therapeutics Market Forecast - Epidemiology & Pipeline Analysis 2023-2028" report has been added to ResearchAndMarkets.com's...
Global Alzheimer's Drugs Market Report 2023 - 2027: Key Players Include Sanofi, F. Hoffmann-La Roche, Pfizer and Abbott Laboratories
January 24, 2023 09:13 ET
|
Research and Markets
Dublin, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The "Alzheimer's Drugs Market, Global Forecast 2023-2027, Industry Trends, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to ...
Alzheimer's Therapeutics Market Research Report 2022 Featuring Cipla, Torrent Pharma, Unichem, Lannett, Janssen Pharma, Novartis, Zydus Lifesciences, Sun Pharmaceutical, Dr. Reddy's, and Aurobindo
December 13, 2022 05:13 ET
|
Research and Markets
Dublin, Dec. 13, 2022 (GLOBE NEWSWIRE) -- The "Alzheimer's Therapeutics Market Share, Size, Trends By Drug Class, By Distribution Channel, By Region, Segment Forecast, 2022 - 2030" report has been...
Alzheimers Therapeutic Global Market Report 2022: High Estimates of Future Cases Driving Development & Innovation
October 11, 2022 05:18 ET
|
Research and Markets
Dublin, Oct. 11, 2022 (GLOBE NEWSWIRE) -- The "Alzheimers Therapeutic Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
Global Alzheimer's Disease Treatment Market Report 2022: Market is Expected to Reach $6.94 Billion in 2026 at a CAGR of 8.1% - Long-term Forecast to 2031
June 01, 2022 05:23 ET
|
Research and Markets
Dublin, June 01, 2022 (GLOBE NEWSWIRE) -- The "Alzheimer's Disease Treatment Global Market Report 2022: By Drug, By Drug, By Therapeutics" report has been added to ResearchAndMarkets.com's offering....
Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market to Cross $1.52 Billion by 2030 - What Are the Most Investment-Attractive Products, Segments, Applications, and Areas?
March 15, 2022 05:08 ET
|
Research and Markets
Dublin, March 15, 2022 (GLOBE NEWSWIRE) -- The "Global Chemotherapy-Induced Peripheral Neuropathy Market, By Therapy, By Region, Estimation & Forecast, 2017 - 2030" report has been added to...
Global Alzheimer Drugs Market Report 2022: A Market Valued at $6,537.0 Million in 2021 - Forecast to 2027
February 15, 2022 07:08 ET
|
Research and Markets
Dublin, Feb. 15, 2022 (GLOBE NEWSWIRE) -- The "Global Alzheimer Drugs Market (2022 Edition) - Analysis By Drug Class (Cholinergic, Memantine, Combined Drugs, Others), Distribution Channel, By...
Global Alzheimer's Disease Drugs Industry (2020 to 2027) - Market Trajectory & Analytics
March 15, 2021 07:38 ET
|
Research and Markets
Dublin, March 15, 2021 (GLOBE NEWSWIRE) -- The "Alzheimer's Disease Drugs - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19...